首页|缩宫素联合麦角新碱治疗宫缩乏力性产后出血的效果与安全性研究

缩宫素联合麦角新碱治疗宫缩乏力性产后出血的效果与安全性研究

扫码查看
目的 分析缩宫素、麦角新碱联合用药后宫缩乏力性产后出血的疗效改变情况,以及可能存在的治疗安全性问题.方法 方便选取2019年2月—2023年6月东莞市长安医院收治的88例宫缩乏力性产后出血产妇为研究对象,依据不同治疗方法分为对照组(n=44)、观察组(n=44).对照组采用单独缩宫素治疗,观察组采用缩宫素+麦角新碱治疗.对比两组产妇产后出血量、子宫底下降高度、止血效果、不良反应发生率.结果 产后1 h、2 h、12 h、24 h,观察组产妇产后出血量分别为(74.39±9.12)mL、(102.18±13.42)mL、(125.33±28.74)mL、(173.21±28.49)mL,均少于对照组的(88.64±9.50)mL、(140.19±18.66)mL、(179.51±30.20)mL、(230.76±32.81)mL,差异有统计学意义(t=7.178、10.970、8.621、8.785,P均<0.05).产后3 d、5 d,观察组产妇子宫底下降高度均大于对照组,差异有统计学意义(P均<0.05).观察组止血效果分级优于对照组、治疗总有效率高于对照组,差异有统计学意义(P均<0.05).用药期间,两组产妇药物相关不良反应总发生率比较,差异无统计学意义(P>0.05).结论 宫缩乏力性产后出血产妇接受缩宫素+麦角新碱治疗,可有效提升止血效率且用药安全性方面较高.
Study on the Efficacy and Safety of Oxytocin Combined with Ergotrine in the Treatment of Postpartum Hemorrhage Caused by Uterine Fatigue
Objective To analyze the changes in therapeutic effect of combined administration of oxytocin and er-gotrine in postpartum hemorrhage caused by uterine weakness,possible safety problems in treatment.Methods A total of 88 cases of postpartum hemorrhage with uterine fatigue treated in Chang'an Hospital of Dongguan City from Febru-ary 2019 to June 2023 were conveniently selected as the study objects,and were divided into control group(n=44)and observation group(n=44)according to different treatment methods.The control group was treated with oxytocin alone,and the observation group was treated with oxytocin+ergotrine.The amount of postpartum bleeding,descending height of uterine floor,hemostatic effect and incidence of adverse reactions were compared between the two groups.Results At 1 h,2 h,12 h and 24 h after delivery,the postpartum blood loss in the observation group was(74.39±9.12)mL,(102.18±13.42)mL,(125.33±28.74)mL and(173.21±28.49)mL,respectively,they were all lower than(88.64±9.50)mL,(140.19±18.66)mL,(179.51±30.20)mL and(230.76±32.81)mL in the control group,and the differ-ences were statistically significant(t=7.178,10.970,8.621,8.785,all P<0.05).On the 3rd and 5th day after delivery,the descending height of uterine floor in the observation group was higher than that in the control group,and the differ-ences were statistically significant(both P<0.05).The hemostatic effect of the observation group was better than that of the control group,and the total effective rate of treatment was higher than that of the control group,the differences were statistically significant(both P<0.05).There was no significant difference in the total incidence of drug-related adverse reactions between the two groups(P>0.05).Conclusion The treatment of oxytocin+ergometrine in parturients with postpartum hemorrhage due to uterine inertia can effectively improve the hemostatic efficiency and the safety of medication.

Postpartum hemorrhage due to uterine fatigueOxytocinErgosineUterine floor heightSecurity

刘瑞景、罗秋兰

展开 >

东莞市长安医院妇产科,广东 东莞 523800

宫缩乏力性产后出血 缩宫素 麦角新碱 子宫底高度 安全性

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(32)